| dc.creator |
NAZIROĞLU, Mustafa |
|
| dc.creator |
Nur, Gokhan |
|
| dc.creator |
Deveci, Haci Ahmet |
|
| dc.date |
2016-12-31T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T11:01:21Z |
|
| dc.date.available |
2020-10-06T11:01:21Z |
|
| dc.identifier |
b50c0cb1-39e6-4a32-8604-b4cea8c6ca69 |
|
| dc.identifier |
10.1080/10799893.2017.1369121 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/b50c0cb1-39e6-4a32-8604-b4cea8c6ca69/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/69929 |
|
| dc.description |
Background: Resistance to cisplatin (Cisp) in the treatment of breast cancer is a major obstacle. Alpha-lipoic acid (ALA) has both antioxidant and oxidant properties. ALA has been used on stimulation mechanisms of apoptosis and oxidative stress in the treatment of cancer with a combination of chemotherapeutic agents, although its role on molecular mechanisms in the cancer cells has not been clarified yet. The aim of this study was to evaluate if a combination therapy of ALA with Cisp can alter the effect of this chemotherapy drug in the MCF-7 breast cancer cells. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Synergic prooxidant, apoptotic and TRPV1 channel activator effects of alpha-lipoic acid and cisplatin in MCF-7 breast cancer cells |
|
| dc.type |
info:eu-repo/semantics/article |
|